Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/1999
09/16/1999WO1999046592A1 Regulation of the cell cycle by sterols
09/16/1999WO1999046575A2 Peptides containing a cholesterol recognition sequence and their uses
09/16/1999WO1999046574A2 Antibodies for assessing protein post-translational modification status and methods of making and using the same
09/16/1999WO1999046408A1 Detection of neoplasia by analysis of saliva
09/16/1999WO1999046396A2 Glyphosate as a gametocide
09/16/1999WO1999046393A1 Dna containing transcriptional activation region of gene
09/16/1999WO1999046392A1 Methods and compositions of chemokine-tumor antigen fusion proteins as cancer vaccines
09/16/1999WO1999046387A1 Biosynthetic genes for spinosyn insecticide production
09/16/1999WO1999046386A1 ALK-1 RESPONDS TO TGF-β AND SIGNALS THROUGH SMAD-1 AND SMAD-5
09/16/1999WO1999046385A2 Compositions and methods for the treatment and prevention of metastatic disorders
09/16/1999WO1999046384A2 Human smad3 and smad4 are sequence-specific transcription activators
09/16/1999WO1999046383A1 Human n-type calcium channel isoform and uses thereof
09/16/1999WO1999046382A1 Chondrosarcoma associated genes
09/16/1999WO1999046381A2 Human fgf gene and gene expression products
09/16/1999WO1999046380A2 Human membrane spanning proteins
09/16/1999WO1999046379A2 Human receptor proteins; related reagents and methods
09/16/1999WO1999046378A1 Novel g protein-coupled receptor proteins
09/16/1999WO1999046377A2 A human vanilloid receptor-like cation channel
09/16/1999WO1999046376A1 Receptor from the superfamily of tnt-receptors from the human lung
09/16/1999WO1999046375A2 Human nucleic acid sequences from prostate tissue
09/16/1999WO1999046374A2 Human nucleic acid sequences from prostate tumour tissue
09/16/1999WO1999046373A1 IDENTIFICATION OF PACTOLUS: A β INTEGRIN-LIKE PROTEIN
09/16/1999WO1999046372A2 Ribozymes capable of inhibiting the expression of the ccr5 receptor
09/16/1999WO1999046371A2 Induction of apoptotic or cytotoxic gene expression by adenoviral mediated gene codelivery
09/16/1999WO1999046367A2 Methods of diagnosis and triage using cell activation measures
09/16/1999WO1999046364A1 Vascular endothelial growth factor 2
09/16/1999WO1999046299A1 Improved methods for producing factor viii proteins
09/16/1999WO1999046298A2 Controlling availability or activity of proteins by use of protease inhibitors or receptor fragments
09/16/1999WO1999046296A1 Ecr673: a 7-transmembrane g-protein coupled receptor
09/16/1999WO1999046295A1 A gene homologous to the drosophila b(2)gen gene and putative yeast 26.5kd protein ypr015c
09/16/1999WO1999046294A1 A human chd-1 like gene
09/16/1999WO1999046293A1 A zinc finger protein derived from hematopoietic cells
09/16/1999WO1999046292A1 A human p18 gene (cbdara04)
09/16/1999WO1999046291A1 A human glia maturation factor (gmf) beta homolog gene (cbfboe11)
09/16/1999WO1999046290A1 A human angiotensin ii/vasopressin receptor (aii/avp) like gene (cbdakd01)
09/16/1999WO1999046289A1 31 human secreted proteins
09/16/1999WO1999046288A2 A process for isolating and purifying viruses, soluble proteins and peptides from plant sources
09/16/1999WO1999046287A1 Secreted proteins and polynucleotides encoding them
09/16/1999WO1999046286A2 Assays and reagents for identifying anti-fungal agents, and uses related thereto
09/16/1999WO1999046284A2 Molecules that home to various selected organs or tissues
09/16/1999WO1999046283A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
09/16/1999WO1999046282A1 Plasminogen-related gene b polypeptides
09/16/1999WO1999046281A2 Novel polypeptides and nucleic acids encoding the same
09/16/1999WO1999046278A1 Viral vector directed to predetermined target cells
09/16/1999WO1999046277A1 HUMAN EDG-1c POLYNUCLEOTIDES AND POLYPEPTIDES AND METHODS OF USE
09/16/1999WO1999046276A1 Zap-1 tumor associated genes and their uses
09/16/1999WO1999046275A1 REPLICATIVE HELICASE dnaB OF $i(STAPHYLOCOCCUS AUREUS)
09/16/1999WO1999046274A1 Modified factor viii
09/16/1999WO1999045962A1 Transgenic non-human animals capable of producing heterologous antibodies
09/16/1999WO1999045961A1 Tertiary structure of peanut allergen ara h 1
09/16/1999WO1999045957A2 Combined vaccine compositions
09/16/1999WO1999045956A1 Vaccines against circovirus infections
09/16/1999WO1999045955A1 DIAGNOSIS, PREVENTION AND TREATMENT OF ULCERATIVE COLITIS, AND CLINICAL SUBTYPES THEREOF, USING MICROBIAL UC pANCA ANTIGENS
09/16/1999WO1999045954A1 Hla-binding peptides and their uses
09/16/1999WO1999045951A2 Thy-1 expression in angiogenesis
09/16/1999WO1999045950A2 Methods of suppressing microglial activation
09/16/1999WO1999045949A2 Use of follistatin to modulate gdf-8 and bmp-11
09/16/1999WO1999045948A1 Reagents for detection and treatment of kaposi's sarcoma
09/16/1999WO1999045947A1 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of alzheimer's and prion diseases
09/16/1999WO1999045944A1 Proapoptotic peptides, dependence polypeptides and methods of use
09/16/1999WO1999045943A1 Enhancement of the pro-fertility action of a molecule involved in sperm-egg binding
09/16/1999WO1999045942A1 Metastatin and hyaluronate binding proteins and methods of use
09/16/1999WO1999045941A1 Peptide compositions and formulations and use of same
09/16/1999WO1999045940A1 Method and composition for lowering low density lipoprotein cholesterol
09/16/1999WO1999045938A1 Thrombin preparation and products and fibrin sealant methods employing same
09/16/1999WO1999045894A2 Cosmetic compositions
09/16/1999WO1999045777A1 Compositions and methods for treatment of asthma
09/16/1999WO1999045767A1 Non-human transgenic mammal, method for producing same and its use
09/16/1999WO1999038967A3 Recombinant proteins derived from hgf and msp
09/16/1999WO1999037782A3 Frozen food product
09/16/1999WO1999037763A3 Novel nucleic acid molecules correlated with the rhesus weak d phenotype
09/16/1999WO1999037673A3 Antifreeze protein
09/16/1999WO1999036511A3 Feline immunodeficiency virus gene therapy vectors
09/16/1999WO1999036440A3 Expression of fusion proteins
09/16/1999WO1999036091A3 Method for inhibiting cd95-independent apoptosis in aids
09/16/1999WO1999035269A3 Method for controlling the division and/or elongation of eukariotic cells
09/16/1999WO1999035106A3 Mammalian edg-7 receptor homologs
09/16/1999WO1999033979A3 Bone marrow secreted proteins and polynucleotides
09/16/1999WO1999033973A3 Cloned octapamine-receptor-producing cells
09/16/1999WO1999033868A3 Human papillomavirus vaccine
09/16/1999WO1999032633A8 Toxoplasma gondii proteins, corresponding nucleic acid molecules, and uses thereof
09/16/1999WO1999032625A3 Nucleotide and protein sequence of mammastatin and methods of use
09/16/1999WO1999032621A3 Nucleic acid sequences encoding nuclear receptor coactivator proteins and uses thereof
09/16/1999WO1999031248A9 INSECT-RESISTANT TRANSGENIC PLANTS AND METHODS FOR IMPROVING δ-ENDOTOXIN ACTIVITY AGAINST TARGET INSECTS
09/16/1999WO1999029882A3 Methods for altering the nutritional value of a plant protein, vegetative storage protein, vsp, by altering the amino acid content of proteins
09/16/1999WO1999029878A3 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system
09/16/1999WO1999025831A3 Slit polypeptide and method of modulation of robo with ligands
09/16/1999WO1999015684A9 Expression of genes in hematopoietic stem cells in hischaemic conditions
09/16/1999WO1999015666A3 Macrophage derived chemokine (mdc), mdc analogs, mdc inhibitor sustances, and uses thereof
09/16/1999WO1999015657A3 53bp2 complexes
09/16/1999WO1999009177B1 Papilloma virus, agents for the detection thereof and for the therapy of the diseases caused by said virus
09/16/1999WO1999002693A8 Microbial swollenin protein; dna sequences encoding such swollenins and method of producing such swollenins
09/16/1999WO1998041531A3 Solvent for biopolymer synthesis, solvent microdroplets and methods of use
09/16/1999WO1996012802A9 Vaccine and antitoxin for treatment and prevention of c. difficile disease
09/16/1999DE19860930A1 Human beta2-adrenergic receptor gene variants, useful for determining an individuals haplotype
09/16/1999DE19815958C1 Non-human mammal - comprises glucocorticoid receptor with altered function in its induced state
09/16/1999DE19811194A1 New nucleic acid expressed at high level in normal prostatic tissue and encoded polypeptides, used to treat cancer and screen for therapeutic agents
09/16/1999DE19811193A1 New nucleic acid expressed at high level in prostatic tumor tissue and encoded polypeptides, useful for treating cancer and screening for therapeutic agents
09/16/1999DE19809978A1 New soluble member of tumor necrosis factor receptor family, useful for identification specific modulators and for treating disease e.g. tumors
09/16/1999CA2588590A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
1 ... 2247 2248 2249 2250 2251 2252 2253 2254 2255 2256 2257 2258 2259 2260 2261 2262 2263 2264 2265 2266 2267 ... 2916